Editorial| Volume 22, ISSUE 9, P1862-1863, September 2021

Download started.


Sarcopenia and SARC-F: “Perfect is the Enemy of Good”

      In this issue of The Journal of the American Medical Directors Association (JAMDA), Voelker and colleagues present the results of a systematic review and meta-analysis measuring the reliability and concurrent validity of the SARC-F.
      • Voelker S.N.
      • Michalopoulos N.
      • Maier A.B.
      • Reijnierse E.M.
      Reliability and concurrent validity of the SARC-F and its modified versions: A systematic review and meta-analysis.
      The study reports data gathered from 29 articles and more than 20,000 participants. Overall, the SARC-F shows relatively good inter-rater and test-retest reliability. However, the authors conclude that despite its high specificity, the low to moderate sensitivity of the SARC-F makes it nonoptimal for the screening of sarcopenia. Moreover, Voelker and colleagues tend to discourage the use of the SARC-F, suggesting the direct application of the diagnostic criteria for sarcopenia without prior screening.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the American Medical Directors Association
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Voelker S.N.
        • Michalopoulos N.
        • Maier A.B.
        • Reijnierse E.M.
        Reliability and concurrent validity of the SARC-F and its modified versions: A systematic review and meta-analysis.
        J Am Med Dir Assoc. 2021; 22: 1864-1876
        • Ida S.
        • Kaneko R.
        • Murata K.
        SARC-F for screening of sarcopenia among older adults: A meta-analysis of screening test accuracy.
        J Am Med Dir Assoc. 2018; 19: 685-689
        • Cao L.
        • Morley J.E.
        Sarcopenia is recognized as an independent condition by an International Classification of Disease, Tenth Revision, Clinical Modification (ICD-10-CM) code.
        J Am Med Dir Assoc. 2016; 17: 675-677
        • Vellas B.
        • Fielding R.
        • Bens C.
        • et al.
        Implications of ICD-10 for sarcopenia clinical practice and clinical trials: Report by the International Conference on Frailty and Sarcopenia Research Task Force.
        J Frailty Aging. 2018; 7: 2-9
        • Sayer A.
        Sarcopenia the new geriatric giant: Time to translate research findings into clinical practice.
        Age Ageing. 2014; 43: 736-737
        • Lim J.
        Sarcopenia: An emerging giant greater than osteoporosis.
        Ann Geriatr Med Res. 2016; 20: 167
        • Cesari M.
        • Fielding R.
        • Pahor M.
        • et al.
        Biomarkers of sarcopenia in clinical trials-recommendations from the International Working Group on Sarcopenia.
        J Cachexia Sarcopenia Muscle. 2012; 3: 181-190
        • Bhasin S.
        • Travison T.G.
        • Manini T.M.
        • et al.
        Sarcopenia definition: The position statements of the Sarcopenia Definition and Outcomes Consortium.
        J Am Geriatr Soc. 2020; 68: 1410-1418
        • Cruz-Jentoft A.
        • Bahat G.
        • Bauer J.
        • et al.
        Sarcopenia: Revised European consensus on definition and diagnosis.
        Age Ageing. 2019; 48: 16-31
        • Chen L.K.
        • Woo J.
        • Assantachai P.
        • et al.
        Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment.
        J Am Med Dir Assoc. 2020; 21: 300-307.e2
        • Beaudart C.
        • McCloskey E.
        • Bruyère O.
        • et al.
        Sarcopenia in daily practice: Assessment and management.
        BMC Geriatr. 2016; 16: 170
        • Reginster J.Y.
        • Beaudart C.
        • Al-Daghri N.
        • et al.
        Update on the ESCEO recommendation for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia in older adults.
        Aging Clin Exp Res. 2021; 33: 3-17
        • Gilliot S.
        • Bastijns S.
        • Perkisas S.
        Investigating sarcopenia awareness using Google Trends.
        J Frailty Sarcopenia Falls. 2021; 6: 32-35
        • Rolland Y.
        • Czerwinski S.
        • Abellan Van Kan G.
        • et al.
        Sarcopenia: Its assessment, etiology, pathogenesis, consequences and future perspectives.
        J Nutr Health Aging. 2008; 12: 433-450
        • Malmstrom T.
        • Morley J.
        SARC-F: A simple questionnaire to rapidly diagnose sarcopenia.
        J Am Med Dir Assoc. 2013; 14: 531-532
        • Morley J.
        • Little M.
        • Berg-Weger M.
        Rapid geriatric assessment: A tool for primary care physicians.
        J Am Med Dir Assoc. 2017; 18: 195-199
        • Woo J.
        • Yu R.
        • Leung J.
        A 3-item SARC-F.
        J Am Med Dir Assoc. 2018; 19: 223-228
        • Malmstrom T.K.
        • Miller D.K.
        • Simonsick E.M.
        • et al.
        SARC-F: A symptom score to predict persons with sarcopenia at risk for poor functional outcomes.
        J Cachexia Sarcopenia Muscle. 2016; 7: 28-36